T. Rowe Price Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $213M | Sell |
|
|||||
|
2025
Q2 | $179M | Sell |
|
|||||
|
2025
Q1 | $129M | Sell |
|
|||||
|
2024
Q4 | $150M | Buy |
|
|||||
|
2024
Q3 | $129M | Buy |
|
|||||
|
2024
Q2 | $147M | Buy |
|
|||||
|
2024
Q1 | $184M | Sell |
|
|||||
|
2023
Q4 | $226M | Sell |
|
|||||
|
2023
Q3 | $166M | Buy |
|
|||||
|
2023
Q2 | $205M | Sell |
|
|||||
|
2023
Q1 | $166M | Buy |
|
|||||
|
2022
Q4 | $122M | Buy |
|
|||||
|
2022
Q3 | $146M | Buy |
|